Compile Data Set for Download or QSAR
Report error Found 58 Enz. Inhib. hit(s) with all data for entry = 50028727
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26626((5Z)-5-{[3-(trifluoromethyl)phenyl]methylidene}-1,...)
Affinity DataIC50: 24nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26673(CHEMBL391586 | 6-(5-bromo-2-hydroxyphenyl)-2-oxo-4...)
Affinity DataIC50: 50nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM11835(Cancer Res 676916 Compound K00135 | CHEMBL200528 |...)
Affinity DataIC50: 61nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM23408(2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxy-4H-ch...)
Affinity DataIC50: 340nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26668(N-cyclohexyl-3-[3-(trifluoromethyl)phenyl]-[1,2,4]...)
Affinity DataKi:  11nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258853(N-cyclopropyl-3-(3-(trifluoromethyl)phenyl)-[1,2,4...)
Affinity DataKi:  18nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi:  21nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM26697(CHEMBL468280 | 7-chloro-9-ethyl-6-fluoro-1H,3H,4H,...)
Affinity DataKi:  22nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258285(N-(tetrahydro-2H-pyran-4-yl)-3-(3-(trifluoromethyl...)
Affinity DataKi:  44nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258425(N-cyclohexyl-N-methyl-3-(3-(trifluoromethyl)phenyl...)
Affinity DataKi:  49nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258858(N-(cyclopropylmethyl)-3-(3-(trifluoromethyl)phenyl...)
Affinity DataKi:  50nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258284(N-cyclobutyl-3-(3-(trifluoromethyl)phenyl)-[1,2,4]...)
Affinity DataKi:  54nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258286(N-(piperidin-3-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi:  94nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258426(N-methyl-N-(1-methylpiperidin-4-yl)-3-(3-(trifluor...)
Affinity DataKi:  100nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258327(N-(1-methylpiperidin-4-yl)-3-(3-(trifluoromethyl)p...)
Affinity DataKi:  160nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258779(N-cyclopropyl-3-(4-fluorophenyl)-[1,2,4]triazolo[4...)
Affinity DataKi:  210nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  230nMAssay Description:Inhibition of GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258854(N-cyclopropyl-3-(4-(trifluoromethyl)phenyl)-[1,2,4...)
Affinity DataKi:  320nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258857(N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[...)
Affinity DataKi:  410nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258856(N-cyclopropyl-3-(3-fluorophenyl)-[1,2,4]triazolo[4...)
Affinity DataKi:  430nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetAurora kinase A(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi:  800nMAssay Description:Inhibition of Aurora 2More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258811(N-cyclopropyl-3-(4-methoxyphenyl)-[1,2,4]triazolo[...)
Affinity DataKi:  980nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi:  1.40E+3nMAssay Description:Inhibition of FLT3More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258812(N-cyclopropyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyrid...)
Affinity DataKi:  1.80E+3nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetProtein kinase C theta type(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  1.80E+3nMAssay Description:Inhibition of PKCthetaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  2.30E+3nMAssay Description:Inhibition of IRAK4More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  2.30E+3nMAssay Description:Inhibition of FLT3More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  2.30E+3nMAssay Description:Inhibition of JAK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  2.40E+3nMAssay Description:Inhibition of JAK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi:  2.90E+3nMAssay Description:Inhibition of GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi:  3.10E+3nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258813(N-cyclopropyl-3-(2-(trifluoromethyl)phenyl)-[1,2,4...)
Affinity DataKi: >3.30E+3nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258855(N-cyclopropyl-3-(2-fluorophenyl)-[1,2,4]triazolo[4...)
Affinity DataKi: >3.30E+3nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258780(N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[...)
Affinity DataKi: >3.30E+3nMAssay Description:Inhibition of Pim1 assessed as [32P] incorporation preincubated for 15 mins before ATP substrate addition by coupled spectrophotometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of SRCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 14(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of p38alphaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 14(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of p38alphaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetProtein kinase C theta type(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of PKCthetaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of PLK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of PLK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of SRCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase SYK(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of SYKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetTyrosine-protein kinase SYK(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of SYKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetHepatocyte growth factor receptor(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of METMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetHepatocyte growth factor receptor(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of METMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of MAP3K7More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 10(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258424(trans-4-(3-(3-(trifluoromethyl)phenyl)-[1,2,4]tria...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of JNK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 10(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258287(N-(piperidin-4-yl)-3-(3-(trifluoromethyl)phenyl)-[...)
Affinity DataKi: >4.00E+3nMAssay Description:Inhibition of JNK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: